New stroke drug aims to boost recovery for patients who miss Clot-Busting window
Disease control
Recruiting now
This study tests an experimental drug called DM199 in people who have had a moderate stroke and cannot receive standard clot-removal treatments. The goal is to see if DM199 helps improve recovery and reduce disability. About 728 participants will receive either the drug or a plac…
Phase: PHASE2, PHASE3 • Sponsor: DiaMedica Therapeutics Inc • Aim: Disease control
Last updated May 26, 2026 06:02 UTC